AKT-mediated phosphorylation of TSC2 controls stimulus- and tissue-specific mTORC1 signaling and organ growth

Yann Cormerais1,2, Samuel C Lapp1,2,3, Krystle C Kalafut1,2,3

  • 1Department of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA.

Insights

The mechanistic target of rapamycin complex 1 (mTORC1) pathway regulates cell growth. A new mouse model shows that tuberous sclerosis complex 2 (TSC2) phosphorylation is key for mTORC1 activation in specific tissues.

Area of Science:

  • Cellular Biology
  • Physiology
  • Biochemistry

Background:

  • Mechanistic target of rapamycin (mTOR) complex 1 (mTORC1) integrates growth signals to control cell and tissue growth.
  • The precise physiological function of molecular mechanisms regulating mTORC1 signaling in mammalian tissues remains unclear.
  • Previous studies established mTORC1 regulation through biochemical and cell biological methods, but in vivo validation is limited.

Purpose of the Study:

  • To investigate the physiological role of tuberous sclerosis complex 2 (TSC2) phosphorylation in mTORC1 signaling using a genetic mouse model.
  • To characterize the impact of abrogated AKT-mediated TSC2 phosphorylation on mTORC1 activity and organismal growth.
  • To establish a valuable genetic tool for studying mTORC1 regulation in vivo.

Main Methods:

  • Development and characterization of a genetic mouse model (TSC2-5A) lacking five key AKT phosphorylation sites on TSC2.
  • Assessment of body weight, organ weight (brain, skeletal muscle), and mTORC1 signaling activity in TSC2-5A mice.
  • Utilized biochemical and cell biological approaches to analyze mTORC1 pathway regulation.

Main Results:

  • TSC2-5A mice were developmentally normal but exhibited reduced body weight and organ weights.
  • Cell-intrinsic growth factor-stimulated mTORC1 signaling was decreased in TSC2-5A mice.
  • TSC2 phosphorylation by AKT was identified as a critical regulator of mTORC1 in specific tissues.

Conclusions:

  • TSC2 phosphorylation is a significant mechanism for activating mTORC1 signaling in certain mammalian tissues.
  • The TSC2-5A mouse model provides crucial insights into the physiological regulation of mTORC1.
  • This genetic model serves as a powerful tool for future research on mTORC1 pathway dynamics.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.2K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.7K